Serotonergic involvement in the inhibitory effects of repeated buspirone treatment on synaptic transmission in the hippocampus

Eur J Pharmacol. 1989 Aug 11;167(1):21-9. doi: 10.1016/0014-2999(89)90743-7.

Abstract

The effects of acute and long-term treatment with buspirone on synaptic transmission in the hippocampus were compared in alert rats with chronic indwelling electrodes and cannula. Buspirone produced a transient dose-dependent reduction in the amplitude of the excitatory postsynaptic potential (EPSP) when acutely injected either systemically (0.3-3.0 mg/kg i.p.) or directly into the hippocampus (0.1-1.0 microgram i.h.). Whereas acute application of 0.5 mg/kg i.p. produced a 20% reduction which reversed within 2 h, during long-term treatment with this relatively low dose there was a gradual reduction of the baseline EPSP amplitude which reached a maximum (40%) between days 7-14 and which did not reverse completely until 72 h after the last injection. Intrahippocampal injection of either buspirone or 5-hydroxytryptamine did not have any additional effect during the period of baseline reduction. The 5-HT1A receptor antagonist spiroxatrine (1 mg/kg i.p.) produced a transient reversal of the effect of chronic buspirone. It is concluded that the chronic inhibitory effect of buspirone is probably an extension of its acute action on 5-HT1A receptors in the hippocampus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Buspirone / administration & dosage
  • Buspirone / pharmacology*
  • Dioxanes / administration & dosage
  • Dioxanes / pharmacology
  • Dose-Response Relationship, Drug
  • Hippocampus / drug effects*
  • Hippocampus / physiology
  • Male
  • Membrane Potentials
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin / drug effects*
  • Receptors, Serotonin / physiology
  • Serotonin / pharmacology
  • Serotonin / physiology*
  • Spiro Compounds / administration & dosage
  • Spiro Compounds / pharmacology
  • Synaptic Transmission / drug effects*
  • Time Factors

Substances

  • Dioxanes
  • Receptors, Serotonin
  • Spiro Compounds
  • Serotonin
  • spiroxatrine
  • Buspirone